VAERS reports by lot

Pfizer COVID-19 lot FJ1614: VAERS reports

460 VAERS reports list lot FJ1614 as a Pfizer COVID-19 vaccine, received between 2021-12-31 and 2024-08-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
460
Reports
19%
Marked serious
5
With a death outcome
22
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)45924%
Neurological32017%
Cardiac / Cardiovascular27814%
Gastrointestinal23912%
Respiratory1528%
Musculoskeletal1246%
Injection-site / Local reaction1216%
Dermatological (non-injection-site)854%
Allergic / Anaphylactic673%
Thrombotic / Hematological362%
Psychiatric / Neuropsychiatric352%
Autoimmune / Immune-mediated171%
Reproductive / Menstrual40%

Where reports came from

U.S. state of the reporter, where given (top 12).

California48
Illinois31
New York28
Ohio24
Texas24
Florida20
Georgia17
Virginia16
Indiana15
Wisconsin14
Michigan14
Pennsylvania14

Reports by month received

2021-121
2022-01178
2022-0299
2022-0356
2022-0414
2022-0518
2022-066
2022-0719
2022-088
2022-093
2022-103
2022-116
2022-121
2023-019
2023-027
2023-033
2023-047
2023-057
2023-066
2023-085
2024-021
2024-083

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.